Related Experiment Videos

[Gene expression of beta-adrenoceptor signal transmitters in heart failure]

X Yu1, S Lin, X Wang

  • 1Guangdong Provincial Cardiovascular Institute, Guangzhou 510080.

Zhonghua Yi Xue Za Zhi
|October 17, 2001
PubMed
Abstract

Insights

Heart failure alters messenger RNA (mRNA) levels of beta-adrenergic signaling molecules. Key changes include increased adenylate cyclase (AC) and CREB mRNA, and decreased beta-2 adrenergic receptor (beta-2 AR) mRNA.

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Genetics

Context:

  • Heart failure is a complex cardiovascular disease.
  • Beta-adrenergic signaling plays a crucial role in cardiac function.
  • Alterations in gene expression are implicated in heart failure pathogenesis.

Purpose:

  • To investigate messenger RNA (mRNA) expression levels of beta-adrenoceptor signaling components in heart failure patients.
  • To quantify changes in beta-2 adrenergic receptor (beta-2 AR), adenylate cyclase (AC), beta-2 adrenergic receptor kinase (beta-ARK), beta-arrestin, and cAMP response element binding protein (CREB) mRNA.

Summary:

  • Quantitative reverse transcription polymerase chain reaction (RT-PCR) was used to measure mRNA levels in lymphocytes from healthy subjects and heart failure patients.
  • Results showed selective alterations: significant increases in AC and CREB mRNA, and a significant decrease in beta-2 AR mRNA.
  • mRNA levels for beta-ARK and beta-arrestin remained unchanged.

Impact:

  • Aberrant gene expression of the beta-adrenergic receptor system may contribute to the development of heart failure.
  • Findings provide insights into the molecular mechanisms underlying heart failure.
  • Identifies specific molecular targets for potential therapeutic interventions.

Related Concept Videos